Skip to main content

Obstructive Sleep Apnoea

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Rhine Pharma
Rhine PharmaGermany - Heidelberg
1 program
Multi Frequency Bioimpedance AnalysisN/A1 trial
Active Trials
NCT03092388Completed40Est. Apr 2016
ResMed
ResMedSAN DIEGO, CA
1 program
Novel SystemN/A1 trial
Active Trials
NCT02535234Completed30Est. Jun 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ResMedNovel System
Rhine PharmaMulti Frequency Bioimpedance Analysis

Clinical Trials (2)

Total enrollment: 70 patients across 2 trials

NCT02535234ResMedNovel System

Comparison of Two Continuous Positive Airway Pressure Systems

Start: Apr 2016Est. completion: Jun 201630 patients
N/ACompleted
NCT03092388Rhine PharmaMulti Frequency Bioimpedance Analysis

Leg Fluid Shift in Patients With Chronic Heart Failure and Obstructive or Central Sleep Apnea

Start: Feb 2015Est. completion: Apr 201640 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.